Cargando…
Rationale and design of the PLACID study: a randomised trial comparing the efficacy and safety of inhaled loxapine versus IM aripiprazole in acutely agitated patients with schizophrenia or bipolar disorder
BACKGROUND: The management of acute agitation manifesting in patients with schizophrenia or bipolar disorder requires swift pharmacological intervention to provide rapid symptomatic relief and prevent escalation to aggression and violence. Antipsychotic medications are widely used in this setting an...
Autores principales: | San, L., Estrada, G., Oudovenko, N., Vieta, E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379730/ https://www.ncbi.nlm.nih.gov/pubmed/28376877 http://dx.doi.org/10.1186/s12888-017-1291-5 |
Ejemplares similares
-
Inhaled Loxapine for the Management of Acute Agitation in Bipolar Disorder and Schizophrenia: Expert Review and Commentary in an Era of Change
por: Pacciardi, Bruno, et al.
Publicado: (2019) -
Addressing the need for rapid treatment of agitation in schizophrenia and bipolar disorder: focus on inhaled loxapine as an alternative to injectable agents
por: Citrome, Leslie
Publicado: (2013) -
Inhaled Loxapine for Agitation in Intoxicated Patients: A Case Series
por: Roncero, Carlos, et al.
Publicado: (2017) -
Examining the safety, efficacy, and patient acceptability of inhaled loxapine for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults
por: Faden, Justin, et al.
Publicado: (2019) -
Inhaled Loxapine for the Treatment of Psychiatric Agitation in the Prehospital Setting: A Case Series
por: Cester-Martínez, Armando, et al.
Publicado: (2017)